Efficacy and safety of larotrectinib in patients with TRK fusion breast cancer

被引：0
|
作者：
Rosen, Ezra Y. [1 ]
Italiano, Antoine [2 ]
Juric, Dejan [3 ]
Reeves, John A. [4 ]
Dima, Laura [5 ]
Brega, Nicoletta [4 ]
Drilon, Alexander [1 ,6 ]
机构：
[1] Mem Sloan Kettering Canc Ctr, 1275 York Ave, New York, NY 10021 USA
[2] Inst Bergonie, Early Phase Trials Unit, Bordeaux, France
[3] Massachusetts Gen Hosp, Ctr Canc, Boston, MA USA
[4] Bayer HealthCare Pharmaceut, Whippany, NJ USA
[5] Bayer Consumer Care AG, Basel, Switzerland
[6] Weill Cornell Med Coll, New York, NY USA
来源：
CANCER RESEARCH | 2021年 / 81卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
PS11-06
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Efficacy and safety of larotrectinib in patients with TRK fusion gastrointestinal cancer
    Qi, Changsong
    Shen, Lin
    Andre, Thierry
    Chung, Hyun Cheol
    Cannon, Timothy L.
    Garralda, Elena
    Italiano, Antoine
    Rieke, Damian T.
    Liu, Tianshu
    Burcoveanu, Domnita-Ileana
    Neu, Natascha
    Mussi, Chiara E.
    Xu, Rui-Hua
    Hong, David S.
    Drilon, Alexander
    Berlin, Jordan
    EUROPEAN JOURNAL OF CANCER, 2025, 220
  • [2] Efficacy and safety of larotrectinib in patients with TRK fusion gastrointestinal cancer
    Berlin, Jordan
    Hong, David S.
    Deeken, John F.
    Boni, Valentina
    Oh, Do-Youn
    Patel, Jyoti D.
    Nanda, Shivani
    Brega, Nicoletta
    Childs, Barrett H.
    Hyman, David Michael
    Drilon, Alexander E.
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (04)
  • [3] Efficacy and safety of larotrectinib in patients with TRK fusion gastrointestinal cancer
    Leyvraz, S.
    Berlin, J.
    Hong, D. S.
    Deeken, J.
    Valentina, B.
    Oh, D. -Y.
    Patel, J.
    Nanda, S.
    Brega, N.
    Childs, B. H.
    Hyman, D. M.
    Drilon, A.
    ONCOLOGY RESEARCH AND TREATMENT, 2020, 43 (SUPPL 4) : 231 - 232
  • [4] Larotrectinib Efficacy and Safety in Pediatric Patients with TRK Fusion Cancer
    Koga, Yuhki
    PEDIATRIC BLOOD & CANCER, 2020, 67
  • [5] LAROTRECTINIB EFFICACY AND SAFETY IN PEDIATRIC PATIENTS WITH TRK FUSION CANCER
    Albert, Catherine
    Geoerger, Birgit
    van Tilburg, Cornelis
    DuBois, Steven
    Federman, Noah
    Nagasubramanian, Ramamoorthy
    Doz, Francois
    Orbach, Daniel
    Bielack, Stefan
    Shukla, Neerav
    Turpin, Brian
    Casanova, Michela
    Spunt, Sheri
    Nanda, Shivani
    Childs, Barrett
    Pappo, Alberto
    Laetsch, Theodore
    Mascarenhas, Leo
    PEDIATRIC BLOOD & CANCER, 2020, 67 : S10 - S11
  • [6] Larotrectinib Efficacy and Safety in Pediatric Patients with TRK Fusion Cancer
    Geoerger, B.
    van Tilburg, C.
    DuBois, S.
    Albert, C.
    Federman, N.
    Nagasubramanian, R.
    Doz, F.
    Orbach, D.
    Bielack, S.
    Shukla, N.
    Turpin, B.
    Casanova, M.
    Spunt, S.
    Qamoos, H.
    Cox, M.
    Nanda, S.
    Childs, B.
    Pappo, A.
    Laetsch, T.
    Mascarenhas, L.
    PEDIATRIC BLOOD & CANCER, 2019, 66 : S65 - S66
  • [7] Larotrectinib efficacy and safety in adult TRK fusion cancer patients.
    Hong, David S.
    Kummar, Shivaani
    Farago, Anna F.
    Lassen, Ulrik Niels
    Berlin, Jordan
    Schilder, Russell J.
    McDermott, Raymond S.
    Patel, Jyoti D.
    Dowlati, Afshin
    Doebele, Robert Charles
    Tan, Daniel Shao-Weng
    Lee, James J.
    Nanda, Shivani
    Childs, Barrett H.
    Ku, Nora
    Drilon, Alexander E.
    Hyman, David Michael
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
  • [8] Larotrectinib efficacy and safety in pediatric TRK fusion cancer patients.
    van Tilburg, Cornelis Martinus
    DuBois, Steven G.
    Albert, Catherine Michelle
    Federman, Noah
    Nagasubramanian, Ramamoorthy
    Geoerger, Birgit
    Orbach, Daniel
    Bielack, Stefan S.
    Shukla, Neerav Narendra
    Turpin, Brian
    Casanova, Michela
    Spunt, Sheri L.
    Qamoos, Hope
    Nanda, Shivani
    Childs, Barrett H.
    Cox, Michael Craig
    Pappo, Alberto S.
    Laetsch, Theodore Willis
    Mascarenhas, Leo
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
  • [9] Efficacy and safety of larotrectinib in patients with tropomyosin receptor kinase (TRK) fusion lung cancer
    Drilon, A.
    Moreno, V.
    Patel, J.
    Lassen, U. N.
    Solomon, B.
    Rosen, L.
    Leyvraz, S.
    Tan, D. S. W.
    Reeves, J. A.
    Dima, L.
    Brega, N.
    Kummar, S.
    Farago, A. F.
    ANNALS OF ONCOLOGY, 2020, 31 : S834 - S834
  • [10] Efficacy and Safety of Larotrectinib in Patients with Tropomyosin Receptor Kinase (TRK) Fusion Lung Cancer
    Tan, D.
    Farago, A.
    Kummar, S.
    Moreno, V.
    Patel, J.
    Lassen, U.
    Solomon, B.
    Rosen, L.
    Leyvraz, S.
    Reeves, J.
    Brega, N.
    Dima, L.
    Childs, B.
    Drilon, A.
    JOURNAL OF THORACIC ONCOLOGY, 2021, 16 (03) : S176 - S176
12345